OBJECT: The authors previously reported the development of the Wireless Instantaneous Neurotransmitter Concentration System (WINCS) for measuring dopamine and suggested that this technology may be useful for evaluating deep brain stimulation-related neuromodulatory effects on neurotransmitter systems. The WINCS supports fast-scan cyclic voltammetry (FSCV) at a carbon-fiber microelectrode (CFM) for real-time, spatially resolved neurotransmitter measurements. The FSCV parameters used to establish WINCS dopamine measurements are not suitable for serotonin, a neurotransmitter implicated in depression, because they lead to CFM fouling and a loss of sensitivity. Here, the authors incorporate into WINCS a previously described N-shaped waveform applied at a high scan rate to establish wireless serotonin monitoring. METHODS: Optimized for the detection of serotonin, FSCV consisted of an N-shaped waveform scanned linearly from a resting potential of +0.2 to +1.0 V, then to -0.1 V and back to +0.2 V, at a rate of 1000 V/second. Proof-of-principle tests included flow injection analysis and electrically evoked serotonin release in the dorsal raphe nucleus of rat brain slices. RESULTS: Flow cell injection analysis demonstrated that the N waveform, applied at a scan rate of 1000 V/second, significantly reduced serotonin fouling of the CFM, relative to that observed with FSCV parameters for dopamine. In brain slices, WINCS reliably detected subsecond serotonin release in the dorsal raphe nucleus evoked by local high-frequency stimulation. CONCLUSIONS: The authors found that WINCS supported high-fidelity wireless serotonin monitoring by FSCV at a CFM. In the future such measurements of serotonin in large animal models and in humans may help to establish the mechanism of deep brain stimulation for psychiatric disease.
OBJECT: The authors previously reported the development of the Wireless Instantaneous Neurotransmitter Concentration System (WINCS) for measuring dopamine and suggested that this technology may be useful for evaluating deep brain stimulation-related neuromodulatory effects on neurotransmitter systems. The WINCS supports fast-scan cyclic voltammetry (FSCV) at a carbon-fiber microelectrode (CFM) for real-time, spatially resolved neurotransmitter measurements. The FSCV parameters used to establish WINCS dopamine measurements are not suitable for serotonin, a neurotransmitter implicated in depression, because they lead to CFM fouling and a loss of sensitivity. Here, the authors incorporate into WINCS a previously described N-shaped waveform applied at a high scan rate to establish wireless serotonin monitoring. METHODS: Optimized for the detection of serotonin, FSCV consisted of an N-shaped waveform scanned linearly from a resting potential of +0.2 to +1.0 V, then to -0.1 V and back to +0.2 V, at a rate of 1000 V/second. Proof-of-principle tests included flow injection analysis and electrically evoked serotonin release in the dorsal raphe nucleus of rat brain slices. RESULTS: Flow cell injection analysis demonstrated that the N waveform, applied at a scan rate of 1000 V/second, significantly reduced serotonin fouling of the CFM, relative to that observed with FSCV parameters for dopamine. In brain slices, WINCS reliably detected subsecond serotonin release in the dorsal raphe nucleus evoked by local high-frequency stimulation. CONCLUSIONS: The authors found that WINCS supported high-fidelity wireless serotonin monitoring by FSCV at a CFM. In the future such measurements of serotonin in large animal models and in humans may help to establish the mechanism of deep brain stimulation for psychiatric disease.
Authors: Saffron A G Willis-Owen; Maria G Turri; Marcus R Munafò; Paul G Surtees; Nick W J Wainwright; Richard D Brixey; Jonathan Flint Journal: Biol Psychiatry Date: 2005-07-14 Impact factor: 13.382
Authors: J L Houeto; V Mesnage; L Mallet; B Pillon; M Gargiulo; S Tezenas du Moncel; A M Bonnet; B Pidoux; D Dormont; P Cornu; Y Agid Journal: J Neurol Neurosurg Psychiatry Date: 2002-06 Impact factor: 10.154
Authors: Kendall H Lee; Charles D Blaha; Paul A Garris; Pedram Mohseni; April E Horne; Kevin E Bennet; Filippo Agnesi; Jonathan M Bledsoe; Deranda B Lester; Chris Kimble; Hoon-Ki Min; Young-Bo Kim; Zang-Hee Cho Journal: Neuromodulation Date: 2009-04
Authors: Seungleal Brian Paek; Emily Jane Knight; Su-Youne Chang; J Luis Lujan; Dong Pyo Jang; Kevin E Bennet; Kendall H Lee Journal: Biomed Eng Lett Date: 2013-03-01
Authors: James K Trevathan; Ali Yousefi; Hyung Ook Park; John J Bartoletta; Kip A Ludwig; Kendall H Lee; J Luis Lujan Journal: ACS Chem Neurosci Date: 2017-02-06 Impact factor: 4.418
Authors: Jamie J Van Gompel; Su-Youne Chang; Stephan J Goerss; In Yong Kim; Christopher Kimble; Kevin E Bennet; Kendall H Lee Journal: Neurosurg Focus Date: 2010-08 Impact factor: 4.047
Authors: Su-Youne Chang; Inyong Kim; Michael P Marsh; Dong Pyo Jang; Sun-Chul Hwang; Jamie J Van Gompel; Stephan J Goerss; Christopher J Kimble; Kevin E Bennet; Paul A Garris; Charles D Blaha; Kendall H Lee Journal: Mayo Clin Proc Date: 2012-07-16 Impact factor: 7.616
Authors: Su-Youne Chang; Christopher J Kimble; Inyong Kim; Seungleal B Paek; Kenneth R Kressin; Joshua B Boesche; Sidney V Whitlock; Diane R Eaker; Aimen Kasasbeh; April E Horne; Charles D Blaha; Kevin E Bennet; Kendall H Lee Journal: J Neurosurg Date: 2013-10-11 Impact factor: 5.115